Smart bombs versus blunderbusses: high-dose chemotherapy for breast cancer.

Detalles Bibliográficos
Publicado en:Lancet Vol. 364; no. 9442; pp. 1299 - 1301
Autor principal: Crown J
Formato: pictorial Journal Article
Publicado: Lancet 10/9/2004
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106544070&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106544070
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        01406736
        LAN
      jtl: Lancet
      issn: 01406736
      maglogo: N
    pubinfo:
      dt: 10/9/2004
      vid: 364
      iid: 9442
      pid: 1297
      pub: Lancet
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        106544070
        106544070
        2009057012
        10.1016/s0140-6736(04)17207-3
        NLM15474123
        106544070
      ppf: 1299
      ppct: 2
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Smart bombs versus blunderbusses: high-dose chemotherapy for breast cancer.
      aug:
        au: Crown J
        affil: St Vincent's University Hospital, Elm Park, Dublin 4, Ireland; John.crown@icorg.ie
      sug:
        subj:
          Antineoplastic Agents Administration and Dosage
          Breast Neoplasms Drug Therapy
          Chemotherapy, Cancer Methods
          Antineoplastic Agents Adverse Effects
          Female
          Hematopoietic Stem Cell Transplantation
          Medical Practice, Evidence-Based
          Female
      pubtype: Academic Journal
      doctype:
        pictorial
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N